Table 1.
Clinicopathological features | circNEIL3 expression | P value | miR-432-5p expression | P value | ADAR1 expression | P value | |||
---|---|---|---|---|---|---|---|---|---|
High | Low | High | Low | High | Low | ||||
All cases | 52 | 52 | 52 | 52 | 52 | 52 | |||
Gender | 0.676 | 0.012* | 0.676 | ||||||
Male | 36 | 34 | 29 | 41 | 34 | 36 | |||
Female | 16 | 18 | 23 | 11 | 18 | 16 | |||
Age (year) | 0.527 | 0.527 | 0.527 | ||||||
< 60 | 18 | 15 | 18 | 15 | 15 | 18 | |||
≥ 60 | 34 | 37 | 34 | 37 | 37 | 34 | |||
Serum CA199 (U/ml) | 0.129 | 0.319 | 0.292 | ||||||
< 39 | 7 | 10 | 11 | 6 | 7 | 10 | |||
≥ 39 | 31 | 36 | 33 | 34 | 32 | 35 | |||
≥ 1000 | 14 | 6 | 8 | 12 | 13 | 7 | |||
Diameter (cm) | 0.098 | 0.033* | 0.033* | ||||||
≤ 4 | 37 | 44 | 45 | 36 | 36 | 45 | |||
> 4 | 15 | 8 | 7 | 16 | 16 | 7 | |||
Location | 0.094 | 0.403 | 0.676 | ||||||
Head | 39 | 31 | 37 | 33 | 36 | 34 | |||
Body and tail | 13 | 21 | 15 | 19 | 16 | 18 | |||
Histological grade | 0.543 | 0.311 | 0.203 | ||||||
I/ I-II | 34 | 31 | 35 | 30 | 32 | 33 | |||
II/ II-III/ III | 18 | 21 | 17 | 22 | 20 | 19 | |||
Microscopic vascular invasion | 0.02* | 0.527 | 0.833 | ||||||
Present | 41 | 30 | 34 | 37 | 35 | 36 | |||
Absent | 11 | 22 | 18 | 15 | 17 | 16 | |||
Microscopic nerve invasion | 0.014* | 0.066 | 0.22 | ||||||
Present | 50 | 42 | 49 | 43 | 48 | 44 | |||
Absent | 2 | 10 | 3 | 9 | 4 | 8 | |||
T stage | 0.168 | 0.844 | 0.554 | ||||||
T1/T2 | 25 | 32 | 29 | 28 | 27 | 30 | |||
T3/T4 | 27 | 20 | 23 | 24 | 25 | 22 | |||
N stage | 0.325 | 0.554 | 0.076 | ||||||
N0 | 21 | 26 | 22 | 25 | 28 | 19 | |||
N1/N2 | 31 | 26 | 30 | 27 | 24 | 33 | |||
M stage | 0.475 | 0.475 | 0.475 | ||||||
M0 | 50 | 52 | 52 | 50 | 50 | 52 | |||
M1 | 2 | 0 | 0 | 2 | 2 | 0 | |||
Clinical stage | 0.146 | 0.534 | 0.299 | ||||||
I-IIa | 14 | 21 | 16 | 19 | 20 | 15 | |||
IIb-IV | 38 | 31 | 36 | 33 | 32 | 37 |
All data are presented as the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001